4-(Furo[2,3-d]pyrimidin-4-ylamino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide

ID: ALA4103338

PubChem CID: 72194909

Max Phase: Preclinical

Molecular Formula: C22H24N8O2

Molecular Weight: 432.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4occc34)cc2)CC1

Standard InChI:  InChI=1S/C22H24N8O2/c1-29-7-9-30(10-8-29)13-15-2-4-16(5-3-15)26-21(31)19-18(12-25-28-19)27-20-17-6-11-32-22(17)24-14-23-20/h2-6,11-12,14H,7-10,13H2,1H3,(H,25,28)(H,26,31)(H,23,24,27)

Standard InChI Key:  OVSVIUOGHPWXNH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    4.3734   -9.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3723  -10.4071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0762  -10.8160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7859  -10.4066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7830   -9.5839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0744   -9.1787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4942  -10.8141    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2013  -10.4044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9096  -10.8118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2000   -9.5872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6656   -9.1791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9539   -9.5879    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9990  -11.6220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7986  -11.7948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2102  -11.0823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6583  -10.4759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8263   -9.6762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2481   -9.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5427   -9.5799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5386  -10.3975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2463  -10.8081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9579  -10.4011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6029   -9.4219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2127   -9.9669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9887   -9.7131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1532   -8.9126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8341  -10.8044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7645   -8.6222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5419   -8.3671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5370   -7.5478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7564   -7.2981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2807   -7.9630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  1 11  1  0
 11 12  1  0
  9 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16  9  1  0
 16 17  1  0
 12 18  1  0
 12 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 17 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 29  1  0
 28 23  1  0
 20 27  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 32 28  1  0
M  END

Associated Targets(Human)

CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin Cyclin-dependent kinase 4/cyclin D1 (2340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A1 (171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 432.49Molecular Weight (Monoisotopic): 432.2022AlogP: 2.69#Rotatable Bonds: 6
Polar Surface Area: 115.21Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.14CX Basic pKa: 7.93CX LogP: 3.48CX LogD: 2.84
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: -1.50

References

1. Wang Y, Zhi Y, Jin Q, Lu S, Lin G, Yuan H, Yang T, Wang Z, Yao C, Ling J, Guo H, Li T, Jin J, Li B, Zhang L, Chen Y, Lu T..  (2018)  Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia.,  61  (4): [PMID:29357250] [10.1021/acs.jmedchem.7b01261]

Source